# Summit Hotel Properties, Inc.: financial statements, quarterly

INN · NYSE · CIK 1497645 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/inn.md) · [Financials](/companies/inn/financials.md) · [Filings](/companies/inn/filings.md) · [Insiders](/companies/inn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/inn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [182](/filings/0001497645-24-000077.md) | [177 d](/filings/0001497645-26-000015.md) | [188](/filings/0001497645-25-000052.md) | [194](/filings/0001497645-25-000091.md) | [177](/filings/0001497645-25-000101.md) | [173 d](/filings/0001497645-26-000015.md) | [184](/filings/0001497645-26-000040.md) | [193](/filings/0001497645-26-000064.md) | [177](/filings/0001497645-25-000101.md) | [175 d](/filings/0001497645-26-000015.md) | [185](/filings/0001497645-26-000040.md) | [199](/filings/0001497645-26-000064.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [16.5](/filings/0001497645-24-000077.md) | [0.4 d](/filings/0001497645-26-000015.md) | [23.5](/filings/0001497645-25-000052.md) | [56.2](/filings/0001497645-25-000091.md) | [15.8](/filings/0001497645-25-000101.md) | [8.0 d](/filings/0001497645-26-000015.md) | [19.8](/filings/0001497645-26-000040.md) | [22.7](/filings/0001497645-26-000064.md) | [8.6](/filings/0001497645-25-000101.md) | [14.6 d](/filings/0001497645-26-000015.md) | [14.1](/filings/0001497645-26-000040.md) | [28.9](/filings/0001497645-26-000064.md) |
| Interest expense | $m | [22.0](/filings/0001497645-23-000058.md) | [21.6 d](/filings/0001497645-24-000013.md) | [21.6](/filings/0001497645-24-000046.md) | [20.8](/filings/0001497645-25-000091.md) | [20.4](/filings/0001497645-25-000101.md) | [19.8 d](/filings/0001497645-26-000015.md) | [20.0](/filings/0001497645-26-000040.md) | [20.6](/filings/0001497645-26-000064.md) | [20.7](/filings/0001497645-25-000101.md) | [19.4 d](/filings/0001497645-26-000015.md) | [20.5](/filings/0001497645-26-000040.md) | [22.1](/filings/0001497645-26-000064.md) |
| Income tax | $m | [1.4](/filings/0001497645-24-000077.md) | [1.1 d](/filings/0001497645-26-000015.md) | [0.2](/filings/0001497645-25-000052.md) | [2.4](/filings/0001497645-25-000091.md) | [0.3](/filings/0001497645-25-000101.md) | [(11.7) d](/filings/0001497645-26-000015.md) | [0.8](/filings/0001497645-26-000040.md) | [1.2](/filings/0001497645-26-000064.md) | [(0.4)](/filings/0001497645-25-000101.md) | [(0.7) d](/filings/0001497645-26-000015.md) | [0.9](/filings/0001497645-26-000040.md) | [(1.4)](/filings/0001497645-26-000064.md) |
| Net income | $m | [(5.8)](/filings/0001497645-24-000077.md) | [(21.3) d](/filings/0001497645-26-000015.md) | [2.8](/filings/0001497645-25-000052.md) | [38.7](/filings/0001497645-25-000091.md) | [(3.6)](/filings/0001497645-25-000101.md) | [0.9 d](/filings/0001497645-26-000015.md) | [0.6](/filings/0001497645-26-000040.md) | [2.0](/filings/0001497645-26-000064.md) | [(11.8)](/filings/0001497645-25-000101.md) | [(2.6) d](/filings/0001497645-26-000015.md) | [(5.9)](/filings/0001497645-26-000040.md) | [9.7](/filings/0001497645-26-000064.md) |
| Diluted EPS | $ per share | [(0.05)](/filings/0001497645-24-000077.md) | not reported | [(0.02)](/filings/0001497645-25-000052.md) | [0.23](/filings/0001497645-25-000091.md) | [(0.04)](/filings/0001497645-25-000101.md) | not reported | [(0.04)](/filings/0001497645-26-000040.md) | [(0.02)](/filings/0001497645-26-000064.md) | [(0.11)](/filings/0001497645-25-000101.md) | not reported | [(0.10)](/filings/0001497645-26-000040.md) | [0.04](/filings/0001497645-26-000064.md) |
| Basic EPS | $ per share | [(0.05)](/filings/0001497645-24-000077.md) | not reported | [(0.02)](/filings/0001497645-25-000052.md) | [0.29](/filings/0001497645-25-000091.md) | [(0.04)](/filings/0001497645-25-000101.md) | not reported | [(0.04)](/filings/0001497645-26-000040.md) | [(0.02)](/filings/0001497645-26-000064.md) | [(0.11)](/filings/0001497645-25-000101.md) | not reported | [(0.10)](/filings/0001497645-26-000040.md) | [0.04](/filings/0001497645-26-000064.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [55.3](/filings/0001497645-24-000077.md) | [37.8](/filings/0001497645-26-000015.md) | [63.4](/filings/0001497645-25-000052.md) | [45.9](/filings/0001497645-25-000091.md) | [51.7](/filings/0001497645-25-000101.md) | [40.6](/filings/0001497645-26-000015.md) | [48.2](/filings/0001497645-26-000040.md) | [39.5](/filings/0001497645-26-000064.md) | [41.1](/filings/0001497645-25-000101.md) | [36.1](/filings/0001497645-26-000064.md) | [44.8](/filings/0001497645-26-000040.md) | [36.9](/filings/0001497645-26-000064.md) |
| Total assets | $m | [3,015](/filings/0001497645-23-000058.md) | [2,939](/filings/0001497645-25-000013.md) | [2,961](/filings/0001497645-24-000046.md) | [2,871](/filings/0001497645-24-000067.md) | [2,837](/filings/0001497645-24-000077.md) | [2,896](/filings/0001497645-26-000015.md) | [2,897](/filings/0001497645-25-000052.md) | [2,868](/filings/0001497645-25-000091.md) | [2,848](/filings/0001497645-25-000101.md) | [2,776](/filings/0001497645-26-000064.md) | [2,755](/filings/0001497645-26-000040.md) | [2,728](/filings/0001497645-26-000064.md) |
| Total liabilities | $m | [1,570](/filings/0001497645-23-000058.md) | [1,543](/filings/0001497645-25-000013.md) | [1,566](/filings/0001497645-24-000046.md) | [1,462](/filings/0001497645-24-000067.md) | [1,464](/filings/0001497645-24-000077.md) | [1,511](/filings/0001497645-26-000015.md) | [1,530](/filings/0001497645-25-000052.md) | [1,539](/filings/0001497645-25-000091.md) | [1,549](/filings/0001497645-25-000101.md) | [1,502](/filings/0001497645-26-000064.md) | [1,505](/filings/0001497645-26-000040.md) | [1,487](/filings/0001497645-26-000064.md) |
| Long-term debt | $m | [1,445](/filings/0001497645-23-000058.md) | [1,431](/filings/0001497645-25-000013.md) | [1,452](/filings/0001497645-24-000046.md) | [1,345](/filings/0001497645-24-000067.md) | [1,336](/filings/0001497645-24-000077.md) | [1,397](/filings/0001497645-26-000015.md) | [1,418](/filings/0001497645-25-000052.md) | [1,426](/filings/0001497645-25-000091.md) | [1,422](/filings/0001497645-25-000101.md) | [1,394](/filings/0001497645-26-000064.md) | [1,396](/filings/0001497645-26-000040.md) | [1,371](/filings/0001497645-26-000064.md) |
| Shareholders' equity | $m | [942](/filings/0001497645-23-000058.md) | [911](/filings/0001497645-25-000013.md) | [908](/filings/0001497645-24-000046.md) | [932](/filings/0001497645-24-000067.md) | [911](/filings/0001497645-24-000077.md) | [910](/filings/0001497645-26-000015.md) | [920](/filings/0001497645-25-000052.md) | [895](/filings/0001497645-25-000091.md) | [876](/filings/0001497645-25-000101.md) | [862](/filings/0001497645-26-000064.md) | [840](/filings/0001497645-26-000040.md) | [839](/filings/0001497645-26-000064.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [44.1 d](/filings/0001497645-24-000077.md) | [30.5 d](/filings/0001497645-26-000015.md) | [28.2](/filings/0001497645-25-000052.md) | [50.3 d](/filings/0001497645-25-000091.md) | [55.7 d](/filings/0001497645-25-000101.md) | [32.2 d](/filings/0001497645-26-000015.md) | [25.9](/filings/0001497645-26-000040.md) | [48.8 d](/filings/0001497645-26-000064.md) | [45.8 d](/filings/0001497645-25-000101.md) | [28.5 d](/filings/0001497645-26-000015.md) | [28.1](/filings/0001497645-26-000040.md) | [55.3 d](/filings/0001497645-26-000064.md) |
| Dividends paid | $m | [7.3 d](/filings/0001497645-24-000077.md) | [7.3 d](/filings/0001497645-26-000015.md) | [7.3](/filings/0001497645-25-000052.md) | [9.8 d](/filings/0001497645-25-000091.md) | [9.8 d](/filings/0001497645-25-000101.md) | [9.9 d](/filings/0001497645-26-000015.md) | [10.0](/filings/0001497645-26-000040.md) | [9.8 d](/filings/0001497645-26-000064.md) | [9.6 d](/filings/0001497645-25-000101.md) | [9.6 d](/filings/0001497645-26-000015.md) | [9.6](/filings/0001497645-26-000040.md) | [9.6 d](/filings/0001497645-26-000064.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001497645-25-000101.md) | [0.0 d](/filings/0001497645-26-000015.md) | [0.0](/filings/0001497645-26-000040.md) | [15.4 d](/filings/0001497645-26-000064.md) | [0.0 d](/filings/0001497645-25-000101.md) | [0.0 d](/filings/0001497645-26-000015.md) | [6.0](/filings/0001497645-26-000040.md) | [0.2 d](/filings/0001497645-26-000064.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [105](/filings/0001497645-23-000058.md) | [105](/filings/0001497645-24-000046.md) | [106](/filings/0001497645-24-000067.md) | [106](/filings/0001497645-24-000077.md) | [106](/filings/0001497645-25-000052.md) | [149](/filings/0001497645-25-000091.md) | [106](/filings/0001497645-25-000101.md) | [108](/filings/0001497645-26-000040.md) | [108](/filings/0001497645-26-000064.md) | [106](/filings/0001497645-25-000101.md) | [106](/filings/0001497645-26-000040.md) | [106](/filings/0001497645-26-000064.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 107,853,463 at 2026-07-24, from the cover of the [10-Q filed 2026-08-05](/filings/0001497645-26-000064.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.